Globalizethis aggregates emerald-1 durvalumab information to help you offer the best information support options. Please refer to the information below.
You are looking : emerald-1 durvalumab
1.A Global Study to Evaluate Transarterial Chemoembolization (TACE …
- Author: A
- Publish: 15 days ago
-
Rating: 4
(680 Rating)
-
Highest rating: 5
-
Lowest rating: 1
- Descriptions:
- More :
- Source : https://clinicaltrials.gov/ct2/show/NCT03778957
(680 Rating)
2.EMERALD-1 – Annals of Oncology
- Author: EMERALD-1
- Publish: 1 days ago
-
Rating: 2(1912 Rating)
-
Highest rating: 4
-
Lowest rating: 1
- Descriptions: EMERALD-1 (NCT03778957) is a randomized, double-blind, placebo-controlled, multicenter phase 3 study assessing efficacy and safety for durvalumab …
- More : EMERALD-1 (NCT03778957) is a randomized, double-blind, placebo-controlled, multicenter phase 3 study assessing efficacy and safety for durvalumab …
- Source : https://www.annalsofoncology.org/article/S0923-7534(20)39728-3/fulltext
3.Emerald 1: A Phase III, Randomized, Double-blind, Placebo …
- Author: Emerald
- Publish: 9 days ago
-
Rating: 4(915 Rating)
-
Highest rating: 3
-
Lowest rating: 2
- Descriptions:
- More :
- Source : https://cancer.uillinois.edu/emerald-1-a-phase-iii-randomized-double-blind-placebo-controlled-multicenter-study-of-transarterial-chemoembolization-tace-in-combination-with-either-durvalumab-monotherapy-or-durvalumab-plus-b/
4.Safety and efficacy of durvalumab plus bevacizumab in …
- Author: Safety
- Publish: 0 days ago
-
Rating: 4(878 Rating)
-
Highest rating: 3
-
Lowest rating: 3
- Descriptions:
- More :
- Source : https://ascopubs.org/doi/abs/10.1200/JCO.2022.40.4_suppl.436
5.EMERALD-1: A Phase III, Randomized, Double-blind, Placebo …
- Author: EMERALD-1:
- Publish: 3 days ago
-
Rating: 4(614 Rating)
-
Highest rating: 5
-
Lowest rating: 3
- Descriptions: EMERALD-1: A Phase III, Randomized, Double-blind, Placebo-controlled, … with either Durvalumab Monotherapy or Durvalumab plus Bevacizumab Therapy in …
- More : EMERALD-1: A Phase III, Randomized, Double-blind, Placebo-controlled, … with either Durvalumab Monotherapy or Durvalumab plus Bevacizumab Therapy in …
- Source : https://www.orpha.net/consor/cgi-bin/ResearchTrials_ClinicalTrials.php%3Flng%3DEN%26data_id%3D139643%26ClinicalTrialName%3DEMERALD-1–A-Phase-III–Randomized–Double-blind–Placebo-controlled–Multicenter-Study-of-Transarterial-Chemoembolization–TACE–in-Combination-with-either-Durvalumab-Monotherapy-or-Durvalumab-plus-Bevacizumab-Therapy-in-Patients-with-Locoregional-Hepatocellular-Carcinoma—JP%26title%3DEMERALD-1:%2520A%2520Phase%2520III,%2520Randomized,%2520Double-blind,%2520Placebo-controlled,%2520Multicenter%2520Study%2520of%2520Transarterial%2520Chemoembolization%2520TACE%2520in%2520Combination%2520with%2520either%2520Durvalumab%2520Monotherapy%2520or%2520Durvalumab%2520plus%2520Bevacizumab%2520Therapy%2520in%2520Patients%2520with%2520Locoregional%2520Hepatocellular%2520Carcinoma%2520-%2520JP%26search%3DResearchTrials_ClinicalTrials_Simple
6.[PDF] EMERALD-1 – PosterSessionOnline
- Author: [PDF]
- Publish: 24 days ago
-
Rating: 5(571 Rating)
-
Highest rating: 4
-
Lowest rating: 2
- Descriptions:
- More :
- Source : https://www.postersessiononline.eu/173580348_eu/congresos/LCS2020/aula/-P02_16_LCS2020.pdf
7.Dr Choo Su Pin on ongoing Phase III EMERALD-1 study for cancer …
- Author: Dr
- Publish: 1 days ago
-
Rating: 4(1583 Rating)
-
Highest rating: 4
-
Lowest rating: 2
- Descriptions:
- More :
- Source : https://www.oncoshot.com/blog/7283b32be31740499d4949341f777f0a
8.Clinical Trials – Cleveland Clinic
- Author: Clinical
- Publish: 20 days ago
-
Rating: 2(1709 Rating)
-
Highest rating: 5
-
Lowest rating: 1
- Descriptions: … Combination with either Durvalumab Monotherapy or Durvalumab plus Bevacizumab Therapy in Patients with Locoregional Hepatocellular Carcinoma (EMERALD-1).
- More : … Combination with either Durvalumab Monotherapy or Durvalumab plus Bevacizumab Therapy in Patients with Locoregional Hepatocellular Carcinoma (EMERALD-1).
- Source : https://my.clevelandclinic.org/clinical-trials/1286-a-phase-iii-randomized-double-blind-placebo-controlled-multicenter-study-of-transarterial-chemoembolization-tace-in-combination-with-either-durvalumab-monotherapy-or-durvalumab-plus-bevacizumab-therapy-in-patients-with-locoregional
9.Clinical Trial on Hepatocellular Carcinoma: Durvalumab … – ICH GCP
- Author: Clinical
- Publish: 12 days ago
-
Rating: 2(1319 Rating)
-
Highest rating: 4
-
Lowest rating: 1
- Descriptions: … Combination With Either Durvalumab Monotherapy or Durvalumab Plus Bevacizumab Therapy in Patients With Locoregional Hepatocellular Carcinoma (EMERALD-1) …
- More : … Combination With Either Durvalumab Monotherapy or Durvalumab Plus Bevacizumab Therapy in Patients With Locoregional Hepatocellular Carcinoma (EMERALD-1) …
- Source : https://ichgcp.net/clinical-trials-registry/NCT03778957
With the above information sharing about emerald-1 durvalumab on official and highly reliable information sites will help you get more information.
